|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Mechanisms of isoflurane-induced myocardial preconditioning in rabbits 显示文摘 | Tkachenko I Gamprt AK Faber LH Julali G | 1999 | Anesthesiology1999，90，3： | 1 |
| 2 | Large and ongoing outbreak of haemolytic uraemic syndrome, Germany, May 2011 显示文摘 | Frank C Faber MS Askar M | 2011 | Euro Surveill2011，，： | 1 |
| 3 | Epidemiology of hepatitis A virus infections, Germany, 2007-2008 显示文摘 | Faber MS Stark K Behnke SC | 2009 | Emerg Infect Dis2009，15，： | 1 |
| 4 | Time response of cytochrome P450 1A2 activity on cessation of heavy smoking显示文摘 | Faber MS Fuhr U | 2004 | Clin Pharmacol Ther2004，76，2： | 1 |
| 5 | Assessment of CYP1 A2 activity in clini- eal practice :why, how, and when?' 显示文摘 | Faber MS Jetter A Fuhr U | 2005 | Basie Clin Pharmacol Toxi- col2005，97，3： | 1 |
| 6 | Reducing costs and patient morbidity in the enlerally fed intensive care unit patient显示文摘 | Faber Ms Moses J Korn M | 2005 | JPEN2005，29，1： | 1 |
| 7 | Antibiotics for the common cold: expectations of Germany' s general population显示文摘 | Faber MS Heckenbach K Velasco E | 2010 | Euro Surveill2010，15，19： | 1 |
| 8 | Reducing costs and patient mor- bidity in the enterally fed intensive care unit patient显示文摘 | Faber MS Moses J Korn M | 2005 | J PEN2005，29，1： | 1 |
| 9 | Antibiotics for the common cold:expectations of Germany's general population显示文摘 | Faber MS Heckenbach K Velasco E | 2010 | Euro Surveill2010，，35： | 1 |
| 10 | Large and ongoing outbreak ofhaemoiytic uraemicsyndrome, Germany, May 2011 显示文摘 | Frank C Faber MS Askar M | 2011 | Euro Surveill2011，16，19： | 1 |
| 11 | Reducing costs and patient morbidity in the enterally fed intensive care unit patient显示文摘 | Faber Ms Moses J Korn M | 2005 | JPEN2005，29，1： | 1 |
| 12 | Reducing costs and patient morbidityin the enterally fed intensive care unit patient 显示文摘 | Faber Ms Moses J Kom M | 2005 | JPEN2005，29，1： | 1 |
| 13 | Antibiotics for the common cold:expectations of Germany’s general population显示文摘 | Faber MS Heckenbach K Velasco E | 2010 | Euro Surveil2010，15，19： | 1 |
| 14 | Reducing costs and patient morbidity in the enterally fed intensive care unit patient显示文摘 | Faber Ms Moses J Korn M | 2005 | JPEN2005，29，1： | 1 |
| 15 | Time response of cytochrome P450 1A2 activity on cessation of heavy smoking显示文摘 | Faber MS Fuhr U | 2004 | Clin Pharmacol Ther2004，76，： | 1 |
| 16 | Assessment of CYP1A2 activity in clinical practice: why, how, and when? 显示文摘 | Faber MS Jetter A Fuhr U | 2005 | Basic Clin Pharmacol Toxicol2005，97，： | 1 |
| 17 | Korn M Reducing coats and patient morbidity in the enterally fed intensive care unit patient显示文摘 | Faber MS Mosea J | 2005 | JPEN2005，29，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员